跳至主要内容
临床试验/CTRI/2020/04/024520
CTRI/2020/04/024520已完成未知

Efficacy of Lactulose plus Intravenous Branched Chain Amino Acids versus Lactulose alone in patients of Acute on Chronic Liver Failure with Overt Hepatic Encephalopathy: A prospective Randomized Clinical Trial (BCAA-ACLF Trial) - BCAA-ACLF Trial

Madhumita Premkumar0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with ACLF (CANONIC definition) of any aetiology with HE >= grade 2 as per West-Haven Criteria

排除标准

  • 1. Those who do not consent to participate in the study
  • 2. Patients with structural brain lesions or stroke
  • 3. Inability to obtain informed consent from patient or relatives
  • 4. Severe preexisting cardiopulmonary disease
  • 5. Renal dysfunction (S. Creatinine >= 2mg/dL)
  • 6. Pregnancy/Lactation
  • 7.. Post liver transplant patients
  • 8. HIV infection
  • 9. Patients who are on psychoactive drugs, like sedatives or antidepressants
  • 10. Patients who are too sick to carry out the protocol

研究者

发起方
Madhumita Premkumar

相似试验